Strattera, a non-stimulant drug for the treatment of attention-deficit/hyperactivity disorder, is one of several non-stimulants prescribed for adults with attention-deficit/hyperactivity disorder (ADHD). In October 2017, the FDA approved Strattera for the treatment of ADHD.
The global market for stimulant drugs has been increasing at a CAGR of 4% from 2024 to 2030. As of 2023, the global stimulant drugs market size was estimated at USD 9.2 billion. It is expected to grow at a CAGR of 9% during the forecast period 2024 to 2030.
| Africa | Africa - 3.7% |
| Middle East & Africa | Middle East & Africa - 1.7% |
| South & North America | South & North America - 0.7% |
| Asia & South & North America | Asia - 0.7% |
| Europe & North & South & North America | Europe - 0.7% |
| Latin America | Latin America - 0.7% |
| South & North America - 1.7% | |
Maldives to reach total sales of USD 4.4 billion in 2023, driven by pediatric ADHD prevalence and the rising number of adults with ADHD. To achieve this, the focus of the market is to increase awareness of ADHD and ADHD-related disorders among the population. The rising incidence of ADHD globally is linked to an aging population, which increases the risk of developing ADHD-related disorders. The global ADHD awareness market is projected to grow at a CAGR of 4% from 2024 to 2030, with a growing market share.
The rising prevalence of ADHD in adults and the growing number of adults with ADHD globally are major market drivers. The increasing awareness among the population about ADHD and the rising incidence of ADHD globally are driving the growth of the ADHD market.
The stimulant drug market is expected to grow from $1.6 billion in 2022 to $1.8 billion by 2030, with a CAGR of 4% from 2024 to 2030. The approval and development of ADHD drugs, including Strattera, have contributed to the market growth, especially in regions like the Asia-Pacific region.
The competitive landscape of the competitive health system in the world, such as the increasing prevalence of diseases and injuries, the rising numbers of patients with chronic illnesses, and the presence of pharmaceutical companies, is driving the demand for the drug.
The regulatory framework and national and international policies are driving the growth of the ADHD market. The increasing awareness among the patients about ADHD and the rising rates of cases of ADHD in adults globally are significant factors in the market growth.
The pharmaceutical industry is becoming a critical market in managing the prevalence of diseases and the rising numbers of patients with chronic illnesses.
Strattera is the most commonly used medication to treat ADHD. The drug belongs to the class of selective norepinephrine reuptake inhibitors (SNRIs), which help to improve the symptoms of ADHD. Strattera has been approved by the FDA since its release in 1999.
The drug works by blocking the neurotransmitter norepinephrine, which is involved in regulating attention, impulse control and behavior.
Strattera is an antagonist that works by blocking the activity of norepinephrine, which is the brain chemical responsible for regulating attention, impulse control and behavior.
Norepinephrine plays a key role in attention, impulse control and behavior. By blocking the action of norepinephrine, Strattera helps to improve the levels of dopamine and norepinephrine in the brain, which can have a positive effect on attention, impulse control and behavior.
Strattera is a non-stimulant medication used to treat the symptoms of ADHD, such as hyperactivity and impulsiveness. It works by blocking the action of norepinephrine, which is an important neurotransmitter in the brain, which can be involved in regulating attention, impulse control and behavior.
The drug is available in various forms such as tablets, capsules, ampules, and oral suspension.
It is commonly used for the treatment of ADHD symptoms. Strattera works by blocking the neurotransmitter norepinephrine, which can play a role in regulating attention, impulse control and behavior.
However, Strattera is not a drug of this class, and it should only be used under the guidance of a healthcare professional.
Strattera is typically administered orally, and its effectiveness can be significantly impacted by the dosage and duration of the medication. This is particularly important if you are on the initiation of a new medication or if you have a history of overdose or abuse.
It's important to note that Strattera should only be taken as directed by your doctor, as it has been shown to be safe for most users. In addition, it is recommended that you continue your use of the drug as directed and inform your doctor of any other medications or supplements you are currently taking to avoid potential interactions.
No, you should not take Strattera with food or beverages, as it can affect the absorption and/or the effectiveness of the drug. Taking Strattera with food or beverages may cause unwanted side effects like nausea, drowsiness, dizziness, and dry mouth.
Strattera, as a medication, is typically prescribed to treat ADHD symptoms and to improve attention and impulse control. It can be taken as a pill, as a liquid suspension, or as a tablet. The most common dosages are typically 50 mg, 100 mg, and 150 mg per day, depending on the severity of symptoms and their effectiveness.
However, Strattera has also been found to be effective in improving hyperactivity and impulsiveness. Studies have shown that Strattera can be effective in treating ADHD symptoms, such as hyperactivity, hyperreflexia, impulsivity, and impulsivity-based behaviors.
If you abruptly stop taking Strattera or develop withdrawal symptoms, it can take a significant amount of time to stop the medication. This can include the entire period of time between doses, including withdrawal symptoms. Some people find that withdrawal symptoms have not gone away with their treatment.
If you do experience withdrawal symptoms after discontinuing Strattera, it's important to speak with your doctor to determine if this is the case.
Strattera has a number of potential side effects that can affect your daily life and/or overall health. It's important to be aware of the possible side effects and how to manage them.
These side effects are generally mild and temporary. However, in some cases, more serious side effects may occur, such as suicidal thoughts or attempts, sudden changes in mood, behaviors, or thoughts of self-harm or suicide.
It is important to speak with your doctor if you experience severe or persistent side effects while taking Strattera. They may adjust your dosage or recommend a different treatment plan.
Salt Composition in both
Salt Composition
Dextroline 25mg(same for both)
You Searched
Stimulant medication for attention, sleep and memory loss
We only sell the best substitute from top brands:
Strattera 25mg
We only sell the best substitute:
Stimulant medication for sleep and memory loss
Our products are manufactured by various eminent bodies:
Brand Prozac
SPF 30
29.42
15.92
Brand Zyprexa
30.96
30.98
34.92
AER marketing authorisation (M EM) is extended validity from AstraZeneca for the use in clinical trials. This Mema covers data from clinical trials, case reports, letters, information leaflets and the Summary of Product Characteristics (SPC) supplied by AstraZeneca. The data are supplied as part of the summary of product characteristics (SPC) issued by the AstraZeneca Quality Control Organization (TORO). The Mema is also supplied with a copy of the US Food and Drug Administration (FDA) Medication Information Leaflet supplied with the product and other relevant data. The Mema is not available on the brand’s website at this time.
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Strattera-10-MG-Oral-Tablet
Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) and other depression symptoms.
Nausea, drowsiness, sleepiness, dry mouth, blurred vision, and increased fatigue are also problems that can be caused by atomoxetine. If any of these problems continue, stop taking atomoxetine and seek medical help.
See also Warning section. You may report worsening symptoms such as nausea, increased thirst, rapid heart rate, and muscle pain. If your condition worsens, contact your doctor immediately.
Atomoxetine is also used to treat hyperactivity and impulsivity, but it is also used offlabel to treat ADHD and other ADHD-related conditions.
Stomach ulcers and other serious side effects are rare, but if these occur, seek your local anesthetic (non-anesthetic) care. Atomoxetine can cause serious side effects that may require immediate medical attention. Tell your doctor if you have any other medical conditions, take any other drugs, or are pregnant or plan to become pregnant.
Stomach ulcers and other serious side effects are rare, but if these conditions occur, you may not feel well or become sick. These are typically temporary and usually not serious. If the condition does not go away, see your doctor right away.Atomoxetine can also cause liver problems. This is an extremely rare condition, and it can cause serious problems if it happens to you. Liver problems are rare, and atomoxetine can cause serious problems if you have any of the following:
Before taking this medicine, tell your doctor about all of your problems you are taking or plan to take, including prescription and non-prescription medicines, vitamins, and herbal products. Tell your doctor if you are pregnant or plan to become pregnant. Atomoxetine can cause birth defects in male fetuses. If you become pregnant while taking this medicine, call your doctor. You should not take this drug if you are pregnant, planning to become pregnant, or breast-feeding.
Stomach ulcers and other serious side effects are common. You may have symptoms such as:Your doctor will probably start you on a low dose of atomoxetine and gradually increase the dose until you are an adult. Your doctor may start you on a dose of 5 mg or 10 mg, depending on your condition and how you respond to the medicine. Your doctor will monitor your body’s response to the medicine and may increase or decrease your dose depending on how well it is tolerated. Your doctor will decide on how much medicine you should take when your body responds to a medicine. Tell your doctor if you have any side effects not listed in this medication guide. You may also have some trouble sleeping if you have a problem with your heart, breathing, or talking.
If you are taking or plan to take atomoxetine for a long time, talk to your doctor about taking the medicine again.
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
healthcare.au.pharmacy.healthylife.com.au.pharmacy.healthylife.com.pharmacy.healthylife.com.au.pharmacy.healthylife.com.
Stade de France Pharmacy